RxDoctor Payments DataLook up a doctor →

SECUKINUMAB_COSENTYX_DERMATOLOGY: payments to doctors

Payments that named SECUKINUMAB_COSENTYX_DERMATOLOGY as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$36K
Providers
8
Transactions
14
Average per transaction
$2,560

The per-transaction average — $2,560 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8 providers the average total is $4,480, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$35,844100.0%
← All drugs & devices